# NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PA-27-101
- **Status:** posted
- **Opens:** May 28, 2026
- **Closes:** April 5, 2029
- **CFDA:** 93.853, 93.838, 93.839, 93.866, 93.307, 93.847, 93.394, 93.837, 93.855, 93.313, 93.393, 93.865, 93.350, 93.242, 93.867, 93.233, 93.351, 93.840, 93.859, 93.273, 93.395
- **View on Kontrakk:** https://kontrakk.com/grants/359758

## Description

No description provided.